Target intelligence / Profile preview

Acceptor splice site (3' splice site (or 3′ss))

Target
3' splice site (or 3′ss)
Molecular classification
Other (RNA sequence motif)
01

Overview

The **acceptor splice site** is a conserved nucleotide sequence at the 3' end of an intron, typically featuring the dinucleotide AG, that marks the boundary between the intron and the downstream exon in pre-mRNA. It is recognized by the spliceosome, a complex of snRNPs and proteins including U2AF and U2 snRNP, which bind upstream elements like the branch point and polypyrimidine tract to facilitate precise intron excision and exon joining during splicing. The site is essential for accurate mRNA maturation, with the spliceosome scanning from the branch point to select the first suitable AG, influencing splicing efficiency and isoform production. Mutations or variants creating ectopic AG dinucleotides nearby can activate cryptic sites, leading to aberrant splicing such as exon skipping, intron retention, or frameshifts, which disrupt protein function. These disruptions are implicated in diseases like cancer and genetic disorders, where splice site variants alter gene expression and contribute to pathology, though the site itself is not a protein-based therapeutic target. Non-canonical acceptor sites exist but are rare, handled by minor spliceosomes. Overall, the acceptor splice site ensures proteomic diversity through alternative splicing while maintaining splicing fidelity.

Other names
3' splice site3′ssacceptor site
02

Biological functions

RNA splicingPre-mRNA processingIntron removal and exon ligation
03

Disease associations

Genetic disease (via pathogenic variants causing aberrant splicing)Cancer (splice site mutations leading to missplicing)

Beyond the preview

Go deeper on Acceptor splice site (3' splice site (or 3′ss)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Acceptor splice site (3' splice site (or 3′ss)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call